{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:16:25Z","timestamp":1778890585907,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001502","name":"Blue Cross Blue Shield of Michigan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.adro.2026.102008","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:16:20Z","timestamp":1770999380000},"page":"102008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress in Shortening Treatment Courses for Bone Metastases in a Statewide Quality Consortium"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4003-8535","authenticated-orcid":false,"given":"Luke M.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying (Maggie)","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumoke","family":"Johnson-Olokesusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly C.","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Critchfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrinda","family":"Narayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howayda","family":"Messiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Fakhreddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad","family":"Abu-Isa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102008_bib0001","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.prro.2024.04.018","article-title":"External beam radiation therapy for palliation of symptomatic bone metastases: An ASTRO clinical practice guideline","volume":"14","author":"Alcorn","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2022.05.024","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases","volume":"173","author":"van der Velden","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0003","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2022.06.002","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases","volume":"173","author":"Oldenburger","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0004","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.55409","article-title":"Stereotactic body and conventional radiotherapy for painful bone metastases: A systematic review and meta-analysis","volume":"7","author":"Bindels","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.adro.2026.102008_bib0006","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: A systematic review","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.23.00753","article-title":"Prophylactic radiation therapy versus standard of care for patients with high-risk asymptomatic bone metastases: A multicenter, randomized phase II clinical trial","volume":"42","author":"Gillespie","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0008","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.canrad.2023.04.006","article-title":"Stereotactic body radiation therapy for bone oligometastases","volume":"28","author":"Naessens","year":"2024","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2026.102008_bib0009","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/j.prro.2020.02.011","article-title":"Stereotactic body radiation therapy for nonspine bone metastases: International practice patterns to guide treatment planning","volume":"10","author":"Nguyen","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0010","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102008_bib0011","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/10499091231187999","article-title":"Severity of financial toxicity for patients receiving palliative radiation therapy","volume":"41","author":"Harris","year":"2024","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.adro.2026.102008_bib0012","article-title":"Financial toxicity in radiation oncology: Impact for our patients and for practicing radiation oncologists","volume":"9","author":"Wu","year":"2023","journal-title":"Adv Radiat Oncol"},{"issue":"suppl 1","key":"10.1016\/j.adro.2026.102008_bib0013","first-page":"e597","article-title":"The environmental impact of radiation oncology: The \u201cfootprint\u201d of external beam radiation therapy","volume":"117","author":"Lichter","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijrobp.2018.03.014","article-title":"Patients undergoing radiation therapy are at risk of financial toxicity: A patient-based prospective survey study","volume":"101","author":"Palmer","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0015","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.prro.2016.10.002","article-title":"Development of a model web-based system to support a statewide quality consortium in radiation oncology","volume":"7","author":"Moran","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0016","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijrobp.2022.01.048","article-title":"The Michigan Radiation Oncology Quality Consortium: A novel initiative to improve the quality of radiation oncology care","volume":"113","author":"Jagsi","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0017","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/j.prro.2019.07.005","article-title":"Recommendations for single-fraction radiation therapy and stereotactic body radiation therapy in palliative treatment of bone metastases: A statewide practice patterns survey","volume":"9","author":"Gharzai","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0018","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2018.02.037","article-title":"Contemporary statewide practice pattern assessment of the palliative treatment of bone metastasis","volume":"101","author":"Spratt","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0019","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/j.prro.2021.05.002","article-title":"Contemporary practice patterns for palliative radiation therapy of bone metastases: Impact of a quality improvement project on extended fractionation","volume":"11","author":"Jaworski","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0020","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1200\/JOP.18.00588","article-title":"Trends in radiation for bone metastasis during a period of multiple national quality improvement initiatives","volume":"15","author":"Logan","year":"2019","journal-title":"J Oncol Pract"},{"issue":"10_suppl","key":"10.1016\/j.adro.2026.102008_bib0021","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1200\/OP.2024.20.10_suppl.288","article-title":"Advancing quality of care using a knowledge transfer approach to foster the use of single-fraction radiation therapy","volume":"20","author":"Johnson","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.adro.2026.102008_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100375","article-title":"Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations","volume":"29","author":"Brown","year":"2021","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0023","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.adro.2020.04.001","article-title":"Palliative radiation therapy for oncologic emergencies in the setting of COVID-19: Approaches to balancing risks and benefits","volume":"5","author":"Yerramilli","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0024","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40336-022-00513-9","article-title":"Covid-19 and radiotherapy: A systematic review after 2 years of pandemic","volume":"10","author":"Piras","year":"2022","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.adro.2026.102008_bib0025","article-title":"Trends in radiation oncology treatment fractionation at a single academic center, 2010 to 2020","volume":"7","author":"Bay","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0026","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","article-title":"Single versus multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial","volume":"15","author":"Chow","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0027","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2003.10.006","article-title":"Single fraction radiotherapy is efficacious: A further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment","volume":"59","author":"van der Linden","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0028","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ijrobp.2025.03.002","article-title":"Reirradiation special medical physics consultations: Lessons learned from nearly 3000 courses of treatment","volume":"122","author":"Paradis","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.11717","article-title":"Implementation strategies to promote short-course radiation for bone metastases","volume":"7","author":"Gillespie","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.adro.2026.102008_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijrobp.2020.08.056","article-title":"Do coordinated knowledge translation campaigns persuade radiation oncologists to use single-fraction radiation therapy compared with multiple-fraction radiation therapy for bone metastases?","volume":"109","author":"Shahhat","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0031","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ijrobp.2014.09.027","article-title":"Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan","volume":"90","author":"Jagsi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0032","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.prro.2023.04.007","article-title":"Prospective evaluation of limited-stage small cell lung cancer radiotherapy fractionation regimen usage and acute toxicity in a large statewide quality collaborative","volume":"13","author":"Allen","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102008_bib0033","article-title":"Microboost in localized prostate cancer: Analysis of a statewide quality consortium","volume":"9","author":"Regan","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"suppl","key":"10.1016\/j.adro.2026.102008_bib0034","doi-asserted-by":"crossref","first-page":"E165","DOI":"10.1016\/j.ijrobp.2025.06.3656","article-title":"Optimizing fractionation strategies for early-stage NSCLC: Real-world toxicity and outcomes from a statewide consortium","volume":"123","author":"Higgins","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102008_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/JOP.091043","article-title":"Partnering with payers for success: Quality oncology practice initiative, Blue Cross Blue Shield of Michigan, and the Michigan Oncology Quality Consortium","volume":"5","author":"Blayney","year":"2009","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.adro.2026.102008_bib0036","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urpr.2014.04.003","article-title":"Quality of Care in Urology and the Michigan Urological Surgery Improvement Collaborative","volume":"1","author":"Montie","year":"2014","journal-title":"Urol Pract"},{"key":"10.1016\/j.adro.2026.102008_bib0037","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2015.10.FOCUS15370","article-title":"The Michigan Spine Surgery Improvement Collaborative: A statewide collaborative quality initiative","volume":"39","author":"Chang","year":"2015","journal-title":"Neurosurg Focus"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:34Z","timestamp":1778889634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2452109426000151"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102008","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in Shortening Treatment Courses for Bone Metastases in a Statewide Quality Consortium","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102008"}}